Open AccessSystemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs
Author(s) -
Shun Jiang,
Sisi Wang,
Qianqian Wang,
Chao Deng,
Yuhua Feng,
Fang Ma,
Jin-an Ma,
Xianling Liu,
Chunhong Hu,
Tao Hou
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s287897
Subject(s) - medicine , erlotinib , adenocarcinoma , oncology , lung cancer , gefitinib , proportional hazards model , exact test , multivariate analysis , survival analysis , biomarker , progression free survival , gastroenterology , cancer , overall survival , epidermal growth factor receptor , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom